Home/Filings/4/0001209191-20-043802
4//SEC Filing

Schelling Chris 4

Accession 0001209191-20-043802

CIK 0001069308other

Filed

Jul 27, 8:00 PM ET

Accepted

Jul 28, 9:00 AM ET

Size

4.9 KB

Accession

0001209191-20-043802

Insider Transaction Report

Form 4
Period: 2020-07-24
Schelling Chris
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2020-07-24$3.50/sh+142,857$500,0001,892,857 total

Issuer

Acer Therapeutics Inc.

CIK 0001069308

Entity typeother

Related Parties

1
  • filerCIK 0001717241

Filing Metadata

Form type
4
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 9:00 AM ET
Size
4.9 KB